Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein.
about
The evolution of poxvirus vaccinesDNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic miApplications of pox virus vectors to vaccination: an update.CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individualsRole of cell signaling in poxvirus-mediated foreign gene expression in mammalian cellsNYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectorsThe next wave of recombinant and synthetic anticancer vaccines.Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.Genetic approaches to the study of cytokine regulation of mucosal immunity.Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors.Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.Biomarker distribution after injection into the canine prostate: implications for gene therapy.
P2860
Q26995905-B2CB2A0A-8A9D-4DD8-A5B9-10E3FF701EC2Q27473069-9B0A76F6-0BD3-4EC4-AED7-AD889C23B5CAQ34403246-9A75A23C-0D8F-40AD-9E14-BCD638425CE5Q34692141-241F2316-9BAC-44D7-A730-2882AB5DDC5CQ35292450-59C9E554-311E-4EB3-A769-CE7A9D594F0DQ35519418-4737A965-5935-45DE-AE91-65B32CA216B5Q35914427-64429CF3-7DDF-4A7E-9C1E-72649FEE42F9Q36470749-DC7F2BD6-04E0-4715-9465-3F5C745983F0Q36638003-B1A83F8B-2B21-4CDD-BC41-9A6854D77B11Q39824887-680207E0-2CB5-46FE-B383-994032325D95Q41036896-FD06A1E3-17DF-4E9B-AD65-B2A0D71B5D59Q45734454-3CB292F3-3A50-419D-B32C-3B277FDE2EFCQ45763976-BADD5245-287F-4CC7-92E3-DC72075C4D69Q45873140-F834189F-965F-4392-8BDB-D0F35E3C7C44
P2860
Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Induction of cytotoxic T lymph ...... e HIV-1 envelope glycoprotein.
@en
Induction of cytotoxic T lymphocytes by recombinant canarypox
@nl
type
label
Induction of cytotoxic T lymph ...... e HIV-1 envelope glycoprotein.
@en
Induction of cytotoxic T lymphocytes by recombinant canarypox
@nl
prefLabel
Induction of cytotoxic T lymph ...... e HIV-1 envelope glycoprotein.
@en
Induction of cytotoxic T lymphocytes by recombinant canarypox
@nl
P2093
P356
P1433
P1476
Induction of cytotoxic T lymph ...... e HIV-1 envelope glycoprotein.
@en
P2093
P304
P356
10.1006/VIRO.1993.1442
P407
P577
1993-08-01T00:00:00Z